Loading company…
Proton Intelligence develops biomarkers and monitoring technology, including continuous potassium measurement.
Founded in 2020 and based in Vancouver, Canada, Proton Intelligence develops tools to diagnose and monitor conditions including cancer, heart disease, and diabetes. Its ProtonPetal product continuously measures potassium in skin interstitial fluid for heart and kidney care. In December 2024, it raised USD 6.95 million in seed funding led by SOSV, with participation from We Venture Capital, Tenmile, LongeVC, 15th Rock, Exor Ventures, and Trampoline Venture.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in